Market Overview - The cosmetics sector experienced a decline of 0.97% on September 2, with Huaye Fragrance leading the drop [1] - The Shanghai Composite Index closed at 3858.13, down 0.45%, while the Shenzhen Component Index closed at 12553.84, down 2.14% [1] Individual Stock Performance - Jiahen Jiahua (300955) saw a significant increase of 7.16%, closing at 35.16 with a trading volume of 127,400 shares and a turnover of 437 million yuan [1] - Other notable gainers included Bawi Co. (837023) with a 3.87% increase and Lafang Jiahua (603630) with a 2.60% increase [1] - Conversely, Huaye Fragrance (300886) led the declines with a drop of 4.05%, closing at 31.55 [2] - The overall performance of the cosmetics sector showed mixed results, with several stocks experiencing declines [2] Capital Flow Analysis - The cosmetics sector saw a net outflow of 216 million yuan from institutional investors, while retail investors contributed a net inflow of 210 million yuan [2] - The table of capital flow indicates that Lafang Jiahua had a net inflow of 49.77 million yuan from institutional investors, despite a net outflow from retail investors [3] - Other companies like Jinxing New Materials (300849) and Shanghai Jahwa (600315) also experienced varying degrees of net inflows and outflows from different investor categories [3]

Group 1 - The cosmetics sector increased by 0.56% on September 1, with Lafang Jiahua leading the gains [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] - Lafang Jiahua's stock price rose by 9.99% to 26.97, with a trading volume of 114,000 shares and a transaction value of 300 million yuan [1] Group 2 - The cosmetics sector saw a net inflow of 15.558 million yuan from institutional investors, while retail investors contributed a net inflow of 45.296 million yuan [2] - Major stocks in the sector experienced varied capital flows, with Lafang Jiahua having a net inflow of 75.247 million yuan from institutional investors [3] - Other companies like Jiahen Jiahua and Huaye Fragrance also saw significant net inflows, while stocks like Marubi Biological and Shanghai Jahwa experienced net outflows from institutional and retail investors [3]

Group 1 - The cosmetics sector increased by 1.05% on August 29, with Jiaheng Jiahua leading the gains [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] - Jiaheng Jiahua's stock price rose by 20.01% to 31.85, with a trading volume of 138,900 shares and a transaction value of 434 million yuan [1] Group 2 - The cosmetics sector saw a net inflow of 10.35 million yuan from institutional investors, while retail investors contributed a net inflow of 88.15 million yuan [2] - Major stocks in the sector experienced varied capital flows, with Jiaheng Jiahua having a net inflow of 76.21 million yuan from institutional investors [3] - Shanghai Jiahua had a net inflow of 35.86 million yuan from institutional investors, but a net outflow of 51.01 million yuan from retail investors [3]

Market Overview - The cosmetics sector experienced a decline of 4.44% on August 27, with Proya leading the drop [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Individual Stock Performance - Key stocks in the cosmetics sector showed varied performance, with Jiahen Jiahua rising by 2.08% to a closing price of 25.03 [1] - Other notable declines included Marubi Biological falling by 2.13% to 40.94, and Shiseido dropping by 3.34% to 25.47 [1][2] Trading Volume and Capital Flow - The total trading volume for the cosmetics sector was significant, with Jiahen Jiahua recording a volume of 195,100 shares and a transaction value of 498 million yuan [1] - The sector saw a net outflow of 580 million yuan from institutional investors, while retail investors contributed a net inflow of 470 million yuan [2] Capital Flow Analysis - Major stocks like Jiahen Jiahua and Marubi Biological experienced mixed capital flows, with Jiahen Jiahua seeing a net outflow of 15.42 million yuan from institutional investors [3] - Conversely, Marubi Biological had a net inflow of 7.79 million yuan from institutional investors, indicating varied investor sentiment across the sector [3]

Core Viewpoint - The financial performance of Jinsong New Materials (300849) in the 2025 mid-year report shows significant declines in both revenue and net profit, indicating a challenging operational environment and potential weaknesses in the business model [1][4]. Financial Performance Summary - Total operating revenue for the first half of 2025 was 151 million yuan, a decrease of 9.33% compared to 167 million yuan in the same period of 2024 [1]. - The net profit attributable to shareholders was -8.80 million yuan, representing a drastic decline of 1663.95% from a profit of 562,500 yuan in the previous year [1]. - The gross profit margin was 18.81%, down by 0.24% year-on-year, while the net profit margin fell to -5.83%, a decrease of 1824.78% [1]. - Total expenses (selling, administrative, and financial) amounted to 30.14 million yuan, accounting for 19.96% of revenue, which is an increase of 21.08% year-on-year [1]. - Earnings per share were -0.06 yuan, a significant drop of 1683.78% from 0 yuan in the previous year [1]. Key Financial Changes - The decrease in operating revenue was attributed to the impact of net accounting for certain glass bottle businesses and a decline in export sales [3]. - The management expenses increased by 14.4% due to depreciation and amortization related to the construction project for cosmetic packaging containers not yet in use [3]. - The financial expenses decreased by 67.79% due to a reduction in financing scale and corresponding interest expenses [3]. - The net cash flow from operating activities saw a drastic decline of 297.16%, influenced by increased domestic sales leading to higher output taxes and a reduction in export tax rebates [3]. - The company reported a significant increase in cash and cash equivalents, with a net increase of 326.78% due to the combined effects of cash flows from investment and financing activities [3]. Business Evaluation - The historical return on invested capital (ROIC) since the company's listing has been relatively low, with a median ROIC of 6.92% and a particularly poor performance in 2022, where ROIC was -3.09% [4]. - The company has experienced three years of losses since its listing, indicating a fragile business model and challenges in maintaining profitability [4].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：300849 证券简称：锦盛新材（维权） 公告编号：2025-025 一、重要提示 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 □适用 √不适用 公司计划不派发现金红利，不送红股，不以公积金转增股本。 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 公司是否需追溯调整或重述以前年度会计数据 □是 √否 单位：股 ■ 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 前10名股东及前10名无限售流通股股东因转融通出借/归还原因导致较上期发生变化 □适用 √不适用 公司是否具有表决权差异安排 □是 √否 二、公司基本情况 1、公司简介 ■ 2、主要会计数据和财务指标 ■ 3、公司股东数量及持股情况 4、控股股东或实际控制人变更情况 控股股东报告期内变更 □适用 ...

Group 1 - The core point of the article is that Jinsheng New Materials (SZ 300849) held its third board meeting on August 25, 2025, to review the proposal for amending the "Rules of Procedure for Special Committee Meetings" [1] - For the fiscal year 2024, the company's revenue composition is entirely from cosmetic packaging, accounting for 100.0% [1]

Group 1 - The company, Jinsheng New Materials, announced the approval of several proposals during the tenth meeting of its third supervisory board, including the 2025 semi-annual report and summary [2]

证券日报网讯8月25日晚间，锦盛新材（300849）发布公告称，公司将于2025年9月16日召开2025年第一 次临时股东大会。本次股东大会将审议《关于修订 <公司章程> 的议案》《关于公司修订、制定相关制 度的议案》等多项议案。 ...

Core Insights - The company, Jinsong New Materials (300849.SZ), reported a revenue of 152 million yuan for the first half of 2025, reflecting a year-on-year decline of 9.33% [1] - The net profit attributable to shareholders turned negative, amounting to -8.7965 million yuan, indicating a shift from profit to loss compared to the previous year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -10.9479 million yuan, further highlighting the company's financial struggles [1] - The basic earnings per share were reported at -0.0586 yuan, indicating a loss per share [1]